Experimental drug shown to 'significantly' slow progression of brain cancer
A new experimental drug was found to "significantly" reduce the progression of brain cancer, Reuters reported.
Vorasidenib, created by Servier Group, a private drug developer, was shown to slow the progression of brain tumors by an average of over 16 months, per Bloomberg. The results of the 331-patient study were published June 4 in The New England Journal of Medicine.
The study's lead author, Ingo Mellinghoff, described this as "a very big finding," adding that the drug "is the first molecularly targeted treatment for diffuse glioma." Vorasidenib specifically works on Grade 2 gliomas, which are "progressive, malignant brain tumors" that are "more common in adults but can also occur in children and teenagers," according to Reuters. The drug blocks a specific enzyme mutated in low-grade gliomas, keeping them from progressing and postponing the need for further treatment like chemotherapy.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"What you just heard is a trial that was well done and well thought out: to use an oral, targeted, well-tolerated therapy to see if we could delay the use of our standard chemotherapy and radiation," Wake Forest Baptist Health's Dr. Glenn Lesser commented at an American Society of Clinical Oncology briefing. "The results are quite striking and they're statistically highly significant, and more importantly, they're clinically very, very significant."
Servier Group is working to get the drug approved by the Food & Drug Administration for use in the U.S.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
The magician who secretly smashed the Magic Circle's glass ceiling
Under The Radar Sophie Lloyd lurked in the all-male society by posing as a teenage boy for nearly two years, but was expelled after revealing her true identity
By Chas Newkey-Burden, The Week UK Published
-
Kate Summerscale's 6 favorite true crime books about real murder cases
Feature The best-selling author recommends works by Helen Garner, Gwen Adshead, and more
By The Week US Published
-
Team of bitter rivals
Opinion Will internal tensions tear apart Trump's unlikely alliance?
By Theunis Bates Published
-
A growing iodine deficiency could bring back America's goiter
Under the Radar Ailment is back thanks to complacency, changing diets and a lack of public-health education
By Harriet Marsden, The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Flame retardants found in black plastics could have health consequences
Under the Radar Time to replace your kitchen tools
By Devika Rao, The Week US Published
-
The 'game-changing' treatment for schizophrenia
The Explainer US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects
By Harriet Marsden, The Week UK Published
-
The audio industry is working to tackle hearing aid stigma
The Explainer Only 1 in 5 people who could benefit from hearing aids use them, according to the Hearing Loss Association of America
By Justin Klawans, The Week US Published
-
Preeclampsia: The dangerous pregnancy condition is affecting more women
Under the Radar The condition of preeclampsia is on the rise and can be deadly if left untreated
By Devika Rao, The Week US Published